COVID-19 Vaccine: Indigenous Scientist Seeks Support to Validate Potential Cure

ksmar September 16, 2020 Headlines, News Leave a comment 619 Views


An indigenous scientist, Chief Apollos Keniyinbo, on Tuesday solicited the support of stakeholders to showcase his research findings, a potential vaccine and cure for the Coronavirus.

Keniyinbo who spoke in Yenagoa said that there was need to look beyond the pharmaceutical and health sector in the developed countries for a vaccine and cure for the virus.

The scientist, who heads Centre for Creative Scientists in Niger Delta, applauded the move by the Federal Ministry of Science and Technology to scrutinise claims of home grown and herbal remedy.

He said the challenge to indigenous scientists motivated him.

Dr Ogbonaya Onu, minister of Science and Technology had on Monday inaugurated a committee on herbal therapies and natural therapies for Coronavirus.

He said that there were several obstacles faced by indigenous scientists like him, who were not in the medical science fields, to submit their remedies for evaluation and validation as the established agencies do not have the mandate to evaluate research findings.

He noted that research was capital intensive and appealed to the three tiers of government to make grants available to scientists with prospects and encourage collaboration amongst indigenous scientists.

 “I am appealing to government at all levels to create an environment that will let the science community to verify and validate what I have done so far. From when the pandemic broke out in China I started working on a solution and in Feb. 2020, my formulation was ready.

 “But as we speak, I have not been given the opportunity to present my findings for scrutiny, I studied analytical chemistry and I am conversant with the procedure and process for vaccine production and I am very willing but I have not been given the attention.

 “I have approached the Bayelsa office of National Agency for Food and Drug Administration and Control (NAFDAC) and my interactions with them showed that they are positioned for drug manufacturing process inspection, registration and regulation and not research findings.

 “The stage of this has not got to mass production yet so I have approached the Southern Ijaw Local Government and Bayelsa Government to help me get the attention of relevant authorities to look at my remedy.

 “I am very sure that my solution is effective and I have even administered it on myself and it is not toxic at all. It is actually composed of four components that form the therapy which I am ready to produce for validation and trials.

 “The solution I have developed is effective for prevention and cure and by using it I have no fear whatsoever of COVID-19.

 “Mine is a combination therapy and administered by injection and the samples I produced are still available. The process has been documented in the scientific format, all that is left is to mass produce the documentation which includes the formulae and dosage modules,’’ Keniyinbo said.

He said that he was being hampered by his inability to get the requisite approvals for trials adding that he would have gone far if the scientific validation process had taken off when he formulated the potential remedy in February. 

Share Post on

Tags

Check Also

Make Methane Reduction a Business Priority, NLNG’s Falade urges Gas Industry

... Says Monetisation Initiative Cut Nigeria’s Gas Flaring from 65% to 20%  By Paul Williams   NLNG has urged the global gas industry to make methane reduction a business priority, adding that every tonne of methane released into the atmosphere represents lost revenue and gas that could otherwise reach the market.  The company said its experience shows that investment in reducing these losses can pay for itself while cutting emissions and improving plant efficiency.  Managing Director and Chief Executive Officer of NLNG, Mr Adeleye Falade, made the call at Gastech 2026 Exhibition and Conference in Bangkok during a panel titled “Capturing the Lost Opportunity: Driving Global Alignment on Methane Abatement Across Natural Gas Supply Chains.”  He said the NLNG approach starts with measuring methane losses and using the findings to guide investment in leak prevention and gas recovery, with independent verification to ensure credible reporting.  Falade said the industry needed to shift the conversation from the cost of methane reduction to the value it creates, recognising that preventing gas losses serves both commercial and environmental objectives.  “Every tonne emitted is lost product, lost revenue and lost energy; gas we could have sold. Every molecule of methane avoided is both an emissions reduction and a recovered energy resource,” he said.  He cited NLNG’s new boil-off gas compressor and start-up gas recovery project as examples of investments that support this approach. Each project targets methane reductions of approximately 10–15 per cent, and both have positive projected net present values, meaning their anticipated financial benefits exceed their costs over the life of the projects.  Falade said, “The most compelling business case is the simplest one: the projects that cut our methane also pay for themselves. The same discipline that reduces methane also improves asset reliability and plant efficiency. The returns show up in more places than the emissions ledger.”  He explained that credible measurement underpins NLNG’s investment decisions, which allows the company to identify methane losses, direct resources to the right interventions and assess the results.  He noted that NLNG’s experience demonstrates that gas producers in developing economies can establish globally trusted emissions-reporting systems by investing in monitoring infrastructure, building reporting capabilities and submitting their data to independent scrutiny.  Falade highlighted NLNG’s Gold Standard recognition under the Oil and Gas Methane Partnership (OGMP) 2.0 and said the company was the first in Africa to achieve Level 5 methane emissions reporting.  He added that its measurement, reporting and verification (MRV) system is independently assured by DNV in accordance with ISO 14064.  NLNG’s approach includes site-wide optical gas imaging, a structured Leak Detection and Repair programme, and the phased deployment of continuous monitoring and real-time dashboards across its plant and vessels.  …

Leave a Reply

Your email address will not be published. Required fields are marked *

Powered & Designed by SuccessTrend Web
© Copyright 2017 - 2026 PhMundial, All Rights Reserved